DMRFusion: A differentially methylated region detection tool based on the ranked fusion method

Area of Science:

• Epigenetics
• Genomics
• Bioinformatics

Background:

• DNA methylation is a key epigenetic mechanism regulating gene expression and cellular function.
• Aberrant DNA methylation patterns are implicated in various diseases, including cancers.
• Identifying differentially methylated regions (DMRs) is crucial for understanding disease mechanisms.

Purpose of the Study:

• To introduce DMRFusion, a novel computational tool for comprehensive DNA methylation analysis.
• To evaluate DMRFusion's performance in identifying DMRs from methylation sequencing data.
• To apply DMRFusion to reduced representation bisulfite sequencing (RRBS) data in chronic lymphocytic leukemia (CLL).

Main Methods:

• DMRFusion integrates multiple ranking methods: Information Gain, Between-Within Class Scatter Ratio, Fisher Ratio, Z-score, and Welch's t-test.
• The tool processes methylation sequencing data, including RRBS.
• Statistical thresholds for significance were set at p-value and FDR < 0.05, with a type I error rate of 0.04.

Main Results:

• DMRFusion successfully identified 30 nominated regions and CpG sites in CLL RRBS data.
• The analysis highlighted hypermethylation in specific DMRs within CLL samples.
• DMRFusion demonstrated efficient and accurate processing, annotation, and visualization of DMRs.

Conclusions:

• DMRFusion is an effective tool for analyzing DNA methylation sequencing data.
• The tool facilitates the discovery of disease-associated DMRs, aiding in biological interpretation.
• DMRFusion provides valuable insights into epigenetic alterations in diseases like CLL.